Spots Global Cancer Trial Database for Study of Karenitecin (BNP1350) in Patients With Brain Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Karenitecin (BNP1350) in Patients With Brain Tumors
Official Title: Phase 2 Treatment of Adults With Primary Malignant Glioma With Karenitecin
Study ID: NCT00062478
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate safety and efficacy ofKarenitecin (BNP1350) as a treatment of adults with brain tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
For Information call 210-614-1701 for a site near you, Durham, North Carolina, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
